Designation of Dr. Srikanth M
Dr. Srikanth M
Hematologist
Senior Consultant – Hematology
Apollo Hospitals, Greams Road, Chennai
Profile Snapshot of Dr. Srikanth M
- Dr. Srikanth M is one of the top Hematologists in Chennai with an experience of 25 years in the field. He practices as the Senior Consultant Hematologist at Apollo Hospital in Greams Road, Chennai.
- He assists patients with an accurate diagnosis, consultation, and treatment for Hemophilia, Leukemia, Myeloma, Thalassemia, Lymphoma, and other blood diseases. In addition, he also offers BMT and Chelation Therapy, etc.
- Dr. Srikanth M has completed MRCP from the Royal College of Physicians, London to enhance his skills and received a fellowship from Royal Marsden Hospital.
- He has contributed many articles and research papers to various publications.
Dr. M Srikanth’s Expertise
- Ablation Therapy
- BMT ( Both Allogeneic BMT & Autologous BMT)
- Aplastic Anemia
- Cancer treatment
- Chelation Therapy
- Hemophilia
- Leukemia
- Myeloma
- Thalassemia
- Lymphoma
- Myelodysplastic Syndrome (MDS) Treatment – Preleukemia
- Sepsis
- Sickle Cell Disease
- Thalassemia
Work Experience of Dr. Srikanth M
- An overall 25 years of experience
- Senior Consultant – Hematology at Apollo Hospital, Chennai
- Royal Marsden Hospital
- St George Health Care, London
- Hammersmith Hospital, London
- Institute of Cancer Research, UK
Dr. M Srikanth’s Qualifications
- MBBS from KMC
- MD (General Medicine) from University College London, UK in 2011
- MRCP (UK) from Royal College Of Physician, London in 2000
- Diploma RCPath (UK)
- CCT (UK), Hematology
Memberships of Dr. Srikanth M
- American Society of Hematology
- Royal College Of Pathologists, UK
- British Society of Hematology
- European Society of Hematology
- Royal College of Physicians, United Kingdom
- Awards & Achievements
- GCRF Fellowship Awarded By Royal Marsden Hospital UK For Performing Research On Multiple Myeloma
- MD Drug Development In Multiple Myeloma from University Of London UK
Publications of Dr. Srikanth M
- Moore HE, Davenport EL, Smith EM, Muralikrishnan S, Dunlop AS, Walker BA, Krige D, Drummond AH, Hooftman L, Morgan GJ, Davies FE. Aminopeptidase Inhibition as a Targeted Treatment Strategy in Myeloma. Molecular Cancer Therapy, 2009: 762-770
- Autophagy is a key myeloma survival pathway that can be manipulated therapeutically to enhance apoptosis; Blood 2010: 408